Skip to main content
SpringerLink
Log in

Erfolgreiche Faktor VIII-Hemmkörperelimination nach Wechsel von „High“- zu „Intermediate-purity“ Faktor-VIII-Konzentrat bei Kindern mit Hämophilie A

  • Conference paper
27. Hämophilie-Symposion Hamburg 1996

Zusammenfassung

In den vergangenen Jahren wurde das Hauptinteresse in der Hämophiliebehandlung der Virussicherheit der Faktorenpräparate gewidmet. Darüber hinaus ist die Behandlung der Hemmkörperhämophilie ein Schwerpunkt, der für die Patienten von vergleichbarer Wichtigkeit ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Schwarzinger I, Pabinger I, Korninger C, Haschke F, Kundi M, Niessner H, Leuchner K (1987) Incidence of Inhibitors in Patients With Severe or Moderate Hemophilia A Treated with Factor VIII Concentrates. A J Hematol 24: 241–245

    Article  CAS  Google Scholar 

  2. Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ (1990) Human recombinant DNA-derived antihemophilic factor ( F VIII) in the treatment of hemophilia A. N Engl J Medt 323: 1799–1805

    Google Scholar 

  3. Rasi V, Ikkala E (1990) Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome. Br J Haematol 76: 369–371

    Article  PubMed  CAS  Google Scholar 

  4. Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, Güngör T, Krackhardt B, Kornhober B (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. The Lancet 339: 594–598

    Article  CAS  Google Scholar 

  5. Kasper CK (1989) Treatment of factor VIII inhibitors. Progr Hemostas Thromb 9: 57–86

    CAS  Google Scholar 

  6. Brackmann HH, Gormsen J (1977) Massive factor VIII infusion in haemoplliliac with factor VIII inhibitor, high responder. Lancet 2: 993

    Google Scholar 

  7. Brackmann HH (1986) Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 150: 181–185

    Google Scholar 

  8. Gomperts ED, Jordan S, Church JA, Sakai R, Lemire J (1984) Induction of tolerance to factor VIII in a child with a high-titer inhibitor: In vitro and in vivo observations. J Pediatr 104: 70

    Article  PubMed  CAS  Google Scholar 

  9. Stenbjerg S, Ingerslev J, Zachariae E (1984) Factor VIII inhibitor treatment with high doses of factor VIII. Thromb Res 34: 533–539

    Article  PubMed  CAS  Google Scholar 

  10. Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenbjerg S, Knudsen JB and the Danish Study Group (1987) Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: A description of eleven patients treated. Thromb Haemostas 58: 1049

    CAS  Google Scholar 

  11. Sultan Y, White GC, Aronstam A, Bosser C, Brackmann HH, Brochier G, Gormsen J, Mariani G, Roberts HR, Scarabin Y, Scharrer I, Scheibel E (1986) Hemophilic patients with an inhibitor to factor VIII treated with high-dose factor VIII concentrate. Nouv Rev Fr Hematol 28: 85–89

    PubMed  CAS  Google Scholar 

  12. Lusher J, Arkin S, Abildgaard CF, Hurst D (1995) Recombinant F VIII (Kogenate)treatment of previously untreated patients (PUPS) with Hemophilia A: Update of safety, efficacy, and inhibitor development after five study years. Thromb Haemost 73 (6): 1012

    Google Scholar 

  13. Bray GI, Schroth P, Lynes M, Buckwalter C, Lee ML (1995) Results from the RecombinateTM (recombinant F VIII concentrate) study of previously untreated patients (PUPS) with Hemophilia A: A 4,5 years follow-up report. Thromb Haemost 73 (6): 1013

    Google Scholar 

  14. Kreuz W, Ehrenforth S, Funk M, Auerswald G, Mentzer D, Joseph-Steiner J, Beeg T, Klarmann D, Scharrer I, Kornhuber B (1994) Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up. Haemophilia 1: 24–32

    Article  Google Scholar 

  15. Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihaemophilic factor on onestage-clotting test: A presamptive test for haemophilia and a simple one-stage antihaemophilic factor assay procedure. J Lab Clin Med 41: 637–645

    PubMed  CAS  Google Scholar 

  16. Lusher JM (1987) Factor VIII Inhibitors. Etiology, characterisation, natural history, and management. Ann NY Acad Sci 509: 89–102

    Article  PubMed  CAS  Google Scholar 

  17. Ewing NP (1990) Induction of Immune Tolerance with Factor VIII concentrate in Patients with Hemophilia A and Inhibitors. In: Kasper CK (ed) Recent Advances in Hemophilia Care. Alan R. Liss, Inc, NY, p 59–68

    Google Scholar 

  18. Hedner U, Glazer S (1992) Management of hemophilia patients with inhibitors. In: Coagulation disorders I. 6; 5: 1035–1046

    Google Scholar 

  19. Ewing NP, Sanders NL, Dietrich SL, Kasper CK (1988) Induction of Immune Tolerance to Factor VIII in Hemophiliacs with Inhibitors. JAMA 259: 65–68

    Article  PubMed  CAS  Google Scholar 

  20. Van Leeuwen EF, Mauser-Bundschoten EP, van Dijken PJ, Kok AJ, Sjamsoedin-Visser EJM, Sixma J (1986) Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose. Br J Haematol 64: 291–297

    Article  PubMed  Google Scholar 

  21. Mauser-Bundschoten EP, Roosendaal G, Bruin M, van Dijken PJ (1990) Disappearance of factor VIII:C antibodies upon frequent administration of factor VIII. Folia-Haematol-IntMag-Klin-Morphol-Blutforsch 117 (4): 533–537

    Google Scholar 

  22. Berntorp E, Ekman M, Gunnarson M, Nilsson IM (1996) Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations. Haemophilia 2: 95–99

    Article  Google Scholar 

Download references

Authors
  1. D. Mentzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Kreuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Auerswald
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentr. d. Inn. Med., Med. Klinik I, Universitätsklinikum, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Deutschland

    Inge Scharrer

  2. Hämostaseologische Abteilung, Med. Univ.-Klinik Innenstadt, Ziemssenstraße 1a, D-80336, München, Deutschland

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Mentzer, D., Kreuz, W., Auerswald, G. (1998). Erfolgreiche Faktor VIII-Hemmkörperelimination nach Wechsel von „High“- zu „Intermediate-purity“ Faktor-VIII-Konzentrat bei Kindern mit Hämophilie A. In: Scharrer, I., Schramm, W. (eds) 27. Hämophilie-Symposion Hamburg 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80403-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80403-8_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62915-3

  • Online ISBN: 978-3-642-80403-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation